Does INLYTA Cause Neoplasm malignant? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Neoplasm malignant have been filed in association with INLYTA. This represents 2.6% of all adverse event reports for INLYTA.
13
Reports of Neoplasm malignant with INLYTA
2.6%
of all INLYTA reports
3
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm malignant From INLYTA?
Of the 13 reports, 3 (23.1%) resulted in death.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INLYTA. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does INLYTA Cause?
Disease progression (97)
Diarrhoea (96)
Death (75)
Fatigue (68)
Nausea (45)
Renal cancer (45)
Dysphonia (40)
Decreased appetite (33)
Asthenia (29)
Hypertension (26)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which INLYTA Alternatives Have Lower Neoplasm malignant Risk?
INLYTA vs INOTERSEN
INLYTA vs INOTUZUMAB OZOGAMICIN
INLYTA vs INSULIN
INLYTA vs INSULIN ASPART
INLYTA vs INSULIN ASPART\INSULIN DEGLUDEC